Change in histological inflammation in patients with ulcerative colitis treated with vedolizumab: Results from the continuing VERDICT trial
Digital Oral Presentation DOP007

SESSION INFORMATION
Presenter: Dr. Vipul Jairath
Date: February 20, 2025
Session Time: 17:45–18:45 PM CET
Presentation Time: 18:21 – 18:27 CET

Target achievement after 48 weeks of vedolizumab treatment in patients with moderate to severe ulcerative colitis: an interim analysis from the VERDICT trial
Digital Oral Presentation DOP050

SESSION INFORMATION
Presenter: Dr. Vipul Jairath
Date: February 21, 2025
Session Time: 08:30–09:30 AM CET
Presentation Time: 08:54 – 09:00 CET

Improvement in biomarkers in patients with ulcerative colitis treated with vedolizumab: Results from the continuing VERDICT trial
Digital Oral Presentation DOP094

SESSION INFORMATION
Presenter: Dr. Vipul Jairath
Date: February 21, 2025
Session Time: 17:45–18:45 PM CET
Presentation Time: 18:03 – 18:09 CET

Reliability of magnetic resonance imaging indices for evaluating perianal fistulizing disease activity in paediatric Crohn’s disease
Poster P0238

SESSION INFORMATION
Presenter: Dr. Eileen Crowley
Date: February 21, 2025
Time: 12:40–13:40 PM CET

Paediatric inflammatory bowel diseases: novel agents on the therapeutic horizon
Poster P0842

SESSION INFORMATION
Presenter: Dr. Eileen Crowley
Date: February 21, 2025
Time: 12:40–13:40 PM CET

Prevalence of immune-mediated extraintestinal manifestations in paediatric inflammatory bowel disease: a systematic review and meta-analysis
Poster P1284

SESSION INFORMATION
Presenter: Dr. Eileen Crowley
Date: February 21, 2025
Time: 12:40–13:40 PM CET

Placebo rates in randomised clinical trials of Ulcerative Colitis: An individual patient data meta-analysis
Poster P0541

SESSION INFORMATION
Presenter: Dr. Virginia Solitano
Date: February 21, 2025
Time: 12:40–13:40 PM CET

A systematic review and quality assessment of clinical practice nursing guidelines for ostomy care
Poster P0935

SESSION INFORMATION
Presenter: Dr. Vipul Jairath
Date: February 21, 2025
Time: 12:40–13:40 PM CET

Development, internal, and external validation of a novel endoscopic activity score for evaluation of Crohn’s disease (EASE-CD)
Poster P0390

SESSION INFORMATION
Presenter: Dr. Christopher Ma
Date: February 21, 2025
Time: 12:40–13:40 PM CET

Improving efficiency in early phase clinical trials for inflammatory bowel disease through use of external control arms
Poster P0831

SESSION INFORMATION
Presenter: Dr. Blue Neustifter
Date: February 21, 2025
Time: 12:40–13:40 PM CET